ARDELYX, INC. Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance
ARDELYX, INC. (ARDX) had Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance of 1.45 million shares as of 2016-12-31, per its 10-K filed 2017-02-17.
Discontinued › Notes › Compensation Related Costs › General
us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance · last filed 2021-03-08
- 2016-12-31: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 1.45M shares.
- 2015-12-31: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 1.45M shares.
- 2014-12-31: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 1.45M shares.
- 2014-06-18: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 1.50M shares; Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance as first filed 1.45M shares.
| Period end | Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance | Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance as first filed |
|---|---|---|
| 2016-12-31 | 1.45M shares 10-K · filed 2017-02-17 | |
| 2015-12-31 | 1.45M shares 10-K · filed 2016-03-04 | |
| 2014-12-31 | 1.45M shares 10-K · filed 2015-03-05 | |
| 2014-06-18 | 1.50M shares 10-K · filed 2021-03-08 | 1.45M shares 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |